Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients
Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients have?
Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients has 18 citations in the OpenAlex counts ScholarIQ stores.
When was Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients published?
Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients has 2020 year in the ScholarIQ index.
What is the open-access status of Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients?
Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients has gold oa status in the ScholarIQ index.
What is the DOI of Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients?
The DOI for Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients is on the source record.
What is the PMID of Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients?
The PMID for Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients is on the source record.
What is the OpenAlex record for Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients?
The OpenAlex for Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients is on the source record.